Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) had Normalized Income after Taxes of $738.68M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$2.06B |
|
$738.68M |
|
$593.86M |
|
$1.47B |
|
$1.04B |
|
$1.02B |
|
$9.16M |
|
$1.03B |
|
$1.03B |
|
$738.68M |
|
$738.68M |
|
$738.68M |
|
|
Normalized Income after Taxes |
$738.68M |
$1.02B |
|
$1.02B |
|
3.29B |
|
3.29B |
|
$0.22 |
|
$0.22 |
|
| Balance Sheet Financials | |
$9.85B |
|
$2.94B |
|
$4.64B |
|
$14.50B |
|
$2.10B |
|
-- |
|
$189.98M |
|
$2.29B |
|
$12.21B |
|
$11.84B |
|
$12.21B |
|
3.29B |
|
| Cash Flow Statement Financials | |
$781.06M |
|
$728.29M |
|
$-1.57B |
|
$2.73B |
|
$2.68B |
|
$-55.16M |
|
-- |
|
$-1.55B |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.70 |
|
-- |
|
-- |
|
-- |
|
-- |
|
71.16% |
|
49.34% |
|
49.34% |
|
-- |
|
49.79% |
|
35.87% |
|
$699.80M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.32 |
|
0.91 |
|
98.73 |
|
6.05% |
|
6.24% |
|
5.10% |
|
6.05% |
|
$3.71 |
|
$0.21 |
|
$0.24 |
|